Your session is about to expire
← Back to Search
Anti-infective Agent
Treatment Arm for Bacterial Vaginosis
Phase 1
Waitlist Available
Led By Sangeeta Jain, MD
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from beginning of labor process until time of delivery
Awards & highlights
Study Summary
This study is evaluating whether a single dose of metronidazole may help reduce infectious morbidities in women with bacterial vaginosis.
Eligible Conditions
- Bacterial Vaginosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days after delivery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days after delivery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of Composite outcome of maternal infections
Secondary outcome measures
Number of days of hospital stay postpartum
Rate of Adverse events
Rate of Chorioamnionitis
+12 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Treatment ArmActive Control1 Intervention
Will receive 4 tablets (2g) of metronidazole oral once.
Group II: Control ArmPlacebo Group1 Intervention
Placebo tablets oral, 4 tablets once.
Find a Location
Who is running the clinical trial?
The University of Texas Medical Branch, GalvestonLead Sponsor
241 Previous Clinical Trials
56,516 Total Patients Enrolled
Sangeeta Jain, MDPrincipal InvestigatorUniversity of Texas medical branch, Galveston
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger